Fellowship in SIDP

Please consider nominating a colleague for this distinction, which is awarded at the SIDP Business Meeting and Lecture Series in the fall. Further information regarding the nomination and application process can be found here.

Elizabeth S. Dodds Ashley, PharmD, MHS, BCPS, FCCP, FIDP

Elizabeth S. Dodds Ashley, PharmD, MHS, is an Associate Professor of Medicine and Director of Operations for the Duke Antimicrobial Stewardship Outreach Network (DASON) based at Duke University.  She has been an active antimicrobial stewardship pharmacist for more than 15 years.  Her work and research in stewardship span a variety of patient care settings including large academic medical centers, community hospitals and long-term care facilities.  She has served as a member of the Antimicrobial Resistance Working Group at the Centers for Disease Control, and an expert panel member of the Transatlantic Taskforce for Antimicrobial Resistance among other appointments.  She currently serves as the Society of Infectious Diseases Pharmacists (SIDP) representative on the Presidential Advisory Council on Antimicrobial Resistant Bacteria (PACCARB).  She is actively involved in several professional societies engaged in stewardship including SHEA and SIDP for which recently served as President.

Amy Lynn Pakyz, MS, PhD, FIDP

In Amy’s short career, she created a legacy for herself and for the ID pharmacy family.  Amy started her career as an Infectious Diseases fellow with Ron Polk.   After fellowship, Amy left VCU for University of Virginia (UVA) and then returned to VCU in a faculty role in the early 2000s. While a full-time faculty member she received her Master’s in Health Evaluation Science at UVA in 2003, and then her PhD in Health Services Organization & Research at VCU in 2013.   Amy received funding from AHRQ and CDC for research related to antimicrobial stewardship and utilization measurement as well as examining the incidence of and risk factors for C. difficile infection.  She authored over 60 peer-reviewed articles and book chapters.   One of Amy’s most significant contributions was her 2008 Archives of Internal Medicine paper “Trends in Antibacterial Use in US Academic Health Centers 2002 to 2006” describing increasing use of antibiotics driven by broad-spectrum agents and vancomycin. 

A proud SIDP member since 1996, Amy served the Society as chairperson, vice-chair or member on nearly every SIDP committee.  Amy was also highly involved with SIDP-partner organizations, including serving on SHEA’s Antimicrobial Stewardship Committee, the Vizient Antimicrobial Stewardship Task Force, and the Virginia Healthcare-associated Infection Advisory Group.

In Amy’s candidacy statement for SIDP Board Member at Large she shared that “I have personally treasured SIDP’s networking and education opportunities. Importantly, I value the comradery with colleagues who face the same challenges I do in infectious diseases pharmacotherapy. I am continually impressed by the enthusiasm and commitment of fellow members. I look forward to the opportunity to give back to SIDP”  

Amy was a wonderful colleague, mentor, and leader across our ID pharmacy community.  She was a quiet achiever and her work was highly impactful.